1. Home
  2. TPST vs NVNI Comparison

TPST vs NVNI Comparison

Compare TPST & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • NVNI
  • Stock Information
  • Founded
  • TPST 2011
  • NVNI 2019
  • Country
  • TPST United States
  • NVNI Brazil
  • Employees
  • TPST N/A
  • NVNI N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • NVNI
  • Sector
  • TPST Health Care
  • NVNI
  • Exchange
  • TPST Nasdaq
  • NVNI Nasdaq
  • Market Cap
  • TPST 33.0M
  • NVNI 31.5M
  • IPO Year
  • TPST N/A
  • NVNI N/A
  • Fundamental
  • Price
  • TPST $7.52
  • NVNI $0.34
  • Analyst Decision
  • TPST Hold
  • NVNI
  • Analyst Count
  • TPST 3
  • NVNI 0
  • Target Price
  • TPST $30.00
  • NVNI N/A
  • AVG Volume (30 Days)
  • TPST 125.6K
  • NVNI 1.4M
  • Earning Date
  • TPST 08-07-2025
  • NVNI 08-07-2025
  • Dividend Yield
  • TPST N/A
  • NVNI N/A
  • EPS Growth
  • TPST N/A
  • NVNI N/A
  • EPS
  • TPST N/A
  • NVNI N/A
  • Revenue
  • TPST N/A
  • NVNI $31,250,627.00
  • Revenue This Year
  • TPST N/A
  • NVNI $12.05
  • Revenue Next Year
  • TPST N/A
  • NVNI $15.02
  • P/E Ratio
  • TPST N/A
  • NVNI N/A
  • Revenue Growth
  • TPST N/A
  • NVNI 1491.58
  • 52 Week Low
  • TPST $5.35
  • NVNI $0.14
  • 52 Week High
  • TPST $30.03
  • NVNI $12.19
  • Technical
  • Relative Strength Index (RSI)
  • TPST 57.33
  • NVNI 51.35
  • Support Level
  • TPST $7.06
  • NVNI $0.28
  • Resistance Level
  • TPST $7.18
  • NVNI $0.38
  • Average True Range (ATR)
  • TPST 0.27
  • NVNI 0.03
  • MACD
  • TPST 0.05
  • NVNI 0.01
  • Stochastic Oscillator
  • TPST 88.57
  • NVNI 64.11

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

Share on Social Networks: